{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "H. R. 3715"}, "official-title": {"#tail": "\n  ", "#text": "To reduce prescription drug costs by allowing the importation and reimportation of certain drugs."}, "session": {"#tail": "\n    ", "#text": "1st Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20131212", "#text": "December 12, 2013"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Ellison", "@name-id": "E000288"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Rohrabacher", "@name-id": "R000409"}}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HD595A414F8BE42C4AF9B83721E710BB5", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "#text": "Personal Drug Importation Fairness Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H1EC91BA3C0CF4669AD2B5491C3EC3D36"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Reducing prescription drug costs by allowing certain drugs to be imported or reimported"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "Notwithstanding any provision of the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", a drug may be imported into the United States, and may be reimported into the United States by a person other than the drug\u2019s manufacturer, if the drug\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et seq", "@value": "usc/21/301/etseq"}, "@parsable-cite": "usc/21/301", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "has the same active ingredients, route of administration, and strength as a prescription drug approved under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "chapter V of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HCF5C18AE64304AB786504D1FE66AB79A", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "may be lawfully marketed in, and is imported or reimported from, a qualified country;"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HE4EE321A01294DD8AAFC9E427F57AF69", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "is dispensed by a licensed pharmacist;"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H5B493EBDC33142D296B154153F8B1327", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "is shipped directly to, or is imported by, the ultimate consumer from the qualified country;"}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H85A36C23E6494824B186C6964E4EEF4C", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "is shipped or imported in quantities that do not exceed a 90-day supply; and"}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "H785E5B1E388D4E73AB35C7EBA87F49B8", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "is accompanied by a copy of a valid prescription."}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "@id": "H0BA5BEABBDD44A6AA5F8D64758801EC0", "#text": "\n          "}], "#text": "\n        ", "@id": "H659A64327D544DF5BAA50A1E279733BA"}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "#text": "In this Act:", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "term": {"#tail": " has the meaning given to such term in ", "#text": "drug"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": ", except that such term excludes any controlled substance (as defined in ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 201 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 321", "@value": "usc/21/321"}, "@parsable-cite": "usc/21/321", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": ").", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 102 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:102"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 802", "@value": "usc/21/802"}, "@parsable-cite": "usc/21/802", "#text": "\n              ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H8347E0C71BD54BCCA5DEC3F760F0A7E6", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "term": {"#tail": " means a drug subject to ", "#text": "prescription drug"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 353(b)(1)", "@value": "usc/21/353/b/1"}, "@parsable-cite": "usc/21/353", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H81519A69C3EF4BB2879A1506D206138C", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n          ", "term": {"#tail": " means a country that\u2014", "#text": "qualified country"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "HC0220AA098314302A7241643EB77E333", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "is Australia, Canada, Israel, Japan, New Zealand, Switzerland, South Africa, a member-state of the European Union, or a country in the European Economic Area; and"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HB09100DF2B234D7BB54F46C1CD4B6302", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to have standards for ensuring the safety and effectiveness of drugs that are at least as protective as such standards in the United States.", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}, "#text": "is determined by the "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H5D2705414FEC449DAA3B0ACC21AF0AA5", "#text": "\n            "}]}], "#text": "\n        ", "@id": "H0426CC2387EA42E39E4AE0248A1370BE"}], "#text": "\n      ", "@id": "HF6E61A524BE641218BDBB75348FD88AE"}], "#text": "\n    ", "@id": "HFF8E1C7E83CC4B2B9976D72C060DD7C7"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-12-12"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 3715 IH: Personal Drug Importation Fairness Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}